Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T A Bayer

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Genes, Brain, and Behavior|February 8, 2008
Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse modelsO Wirths, T A Bayer
Der Nervenarzt|September 30, 2008
[Alzheimer's disease. Molecular pathology, animal models, and current treatment]T A Bayer, O Wirths
Genes, Brain, and Behavior|February 8, 2008
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairmentT A Bayer, O Wirths
Development (Cambridge, England)|June 1, 1992
A transgene containing lacZ is expressed in primary sensory neurons in zebrafishT A Bayer, J A Campos-Ortega
Journal of Psychiatric Research|January 11, 2000
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis"T A Bayer, P Falkai, W Maier
Brain, Behavior, and Immunity|January 10, 2002
Review of immunological and immunopathological findings in schizophreniaM Rothermundt, V Arolt, T A Bayer
Journal of Neural Transmission (Vienna, Austria : 1996)|November 1, 2006
Gender dependent APP processing in a transgenic mouse model of Alzheimer's diseaseS Schäfer, O Wirths, G Multhaup, et al.
Neuroscience Letters|September 7, 1999
Evidence for activation of microglia in patients with psychiatric illnessesT A Bayer, R Buslei, L Havas, et al.
Acta Neuropathologica|January 1, 1995
Hippocampal loss of N-methyl-D-aspartate receptor subunit 1 mRNA in chronic temporal lobe epilepsyT A Bayer, O D Wiestler, H K Wolf
Neuroscience Letters|May 17, 2006
Cholesterol synthesis rate in human hippocampus declines with agingK M Thelen, P Falkai, T A Bayer, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Genes, Brain, and Behavior|February 8, 2008
Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse modelsO Wirths, T A Bayer
Der Nervenarzt|September 30, 2008
[Alzheimer's disease. Molecular pathology, animal models, and current treatment]T A Bayer, O Wirths
Genes, Brain, and Behavior|February 8, 2008
Review on the APP/PS1KI mouse model: intraneuronal Abeta accumulation triggers axonopathy, neuron loss and working memory impairmentT A Bayer, O Wirths
Development (Cambridge, England)|June 1, 1992
A transgene containing lacZ is expressed in primary sensory neurons in zebrafishT A Bayer, J A Campos-Ortega
Journal of Psychiatric Research|January 11, 2000
Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis"T A Bayer, P Falkai, W Maier
Brain, Behavior, and Immunity|January 10, 2002
Review of immunological and immunopathological findings in schizophreniaM Rothermundt, V Arolt, T A Bayer
Journal of Neural Transmission (Vienna, Austria : 1996)|November 1, 2006
Gender dependent APP processing in a transgenic mouse model of Alzheimer's diseaseS Schäfer, O Wirths, G Multhaup, et al.
Neuroscience Letters|September 7, 1999
Evidence for activation of microglia in patients with psychiatric illnessesT A Bayer, R Buslei, L Havas, et al.
Acta Neuropathologica|January 1, 1995
Hippocampal loss of N-methyl-D-aspartate receptor subunit 1 mRNA in chronic temporal lobe epilepsyT A Bayer, O D Wiestler, H K Wolf
Neuroscience Letters|May 17, 2006
Cholesterol synthesis rate in human hippocampus declines with agingK M Thelen, P Falkai, T A Bayer, et al.
Pageof 5